REGEND007
/ Regend Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 23, 2026
Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND007 Cell Therapy
(clinicaltrials.gov)
- P1 | N=12 | Not yet recruiting | Sponsor: Regend Therapeutics
New P1 trial • Idiopathic Pulmonary Fibrosis • Immunology • Pulmonary Disease • Respiratory Diseases
1 to 1
Of
1
Go to page
1